A long-standing explanation for magnetoresistance may be incomplete. New evidence suggests a universal interfacial mechanism ...
Viral vector demand still exceeds capacity, according to analysts who say biopharma firms and CDMOs need new facilities and more efficient production processes. Industry concerns about vector supplies ...